Conditions: Chronic Hepatitis C
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 47
Healthy volunteers: yes

Brief summary:
The purpose of this study is to assess the effect of BMS-790052 on the pharmacokinetics of Ortho Tri-Cyclen® in healthy female subjects.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: BMS-790052 intervention 2: Ortho Tri-Cyclen®
Intervention descriptions: intervention 1: Tablets, Oral, 60 mg, once daily, 10 days intervention 2: Tablets, Oral, once daily, 78 days

Protocol document: